Compliance

Built for clinical research advertising.

Recruitment advertising for research is not like marketing anything else. It runs inside IRB oversight, strict platform health policies, and real participant-privacy obligations. Working within those rules is not a constraint we tolerate. It is the foundation of how every campaign is built.

What we work within

The rules that govern research recruitment

Each of these shapes what an ad can say, where it can run, and how participant information is handled. Campaigns are designed around all of them from the start.

IRB-approved materials

Recruitment creative is developed from your IRB-approved study materials and submitted through your institution's review process before anything runs. Nothing goes live without sign-off.

Meta health advertising policy

Meta restricts how health conditions can be referenced in ads. Copy is written to speak generally and let people self-identify, rather than implying personal health details, which keeps campaigns within policy.

Google health advertising policy

Google applies its own rules to health and clinical research ads. Campaigns are structured to meet those requirements so search and display placements stay eligible to run.

Participant privacy

Interested participants are routed to your approved screener or interest form. Their information goes to your research team, not used for retargeting, list building, or any purpose outside helping direct them to your study.

The review process

Nothing runs until it's approved

Every campaign follows the same path, so your team and your reviewers always see the materials before a participant does.

1

Build from approved materials

Creative and copy are drafted from your IRB-approved study documents.

2

Your team reviews

You and your reviewers see every ad, headline, and landing destination first.

3

Institutional sign-off

Materials go through your institution's review process as required before launch.

4

Launch and monitor

Approved campaigns go live and are monitored, ready to adjust if a platform flags anything.

IRB approval and platform approval are two different things.

A study can be fully IRB-approved and still have its ads rejected by Meta or Google, because the platforms enforce their own separate health-advertising rules. TrialFill builds for both, so your approved study does not get held up by an avoidable ad rejection.

Talk through your study's requirements